Health · Healthcare & Policy · 4 hrs ago
Italian oncologists call for drug budgets that match patient needs
Italy’s oncology association is calling for drug budgets to match patients’ needs as pressure grows to contain spending on cancer medicines.
The Italian Association of Medical Oncology says funding plans should reflect new treatment options and growing care needs.
In recent years, more therapies have become available, and survival and quality of life have improved for many types of cancer.
More people can receive treatment, and some patients can continue it for longer.
The association says doctors cannot manage rising costs through prescribing decisions alone, and that health authorities must also set adequate spending limits.
It warns that budgets based only on past spending could restrict access to care instead of controlling costs effectively.
It is seeking talks with national and regional institutions and health service managers to agree on funding criteria based on patient needs and the value of treatments.
The Italian Association of Medical Oncology (AIOM) called for drug budgets to reflect patients’ treatment needs and advances in cancer care.
It said financial sustainability should not limit access to innovative treatments.
AIOM said cancer drug spending has risen alongside more treatment options, longer treatment courses and increased patient access to care.
It warned that budget targets based only on previous years’ spending could be unrealistic if they do not account for patient numbers and treatment needs.
The association called for discussions with institutions, regions and health-care company managers on needs-based funding criteria.
- Who
- The Italian Association of Medical Oncology (AIOM) and Italian oncologists.
- What
- AIOM called for drug budgets to match patient needs and advances in cancer treatment.
- When
- November 9, 2026. The article does not state when the call was first made.
- Where
- Italy.
- Why
- AIOM said more patients have access to treatment, and some treatments last longer, while many new therapies are costly.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Organization
- Italian Association of Medical Oncology (AIOM)
- Published
- November 9, 2026
- Requested budget approach
- Align resources with patient needs and research advances
- Proposed discussion
- AIOM called for talks with institutions, regions and health-care company managers
What people are saying
Budgets should be adequate to patients’ needs: sustainability must not limit access to innovation.
Oncologists are responsible for the appropriateness of clinical choices, but they cannot compensate for rising costs on their own.
In the absence of resources aligned with needs, the risk is to ration access to care rather than rationalize spending.